This is not seen and may suggest alternate receptor and PIK3CA/mTOR interaction in male breast cancer or a dose-based relationship differentiated by male cancers with low estrogen at one end of the spectrum and higher levels of estrogen in females at the opposite end. The gene discussed is MTOR; the disease is breast cancer.